Zacks Small Cap Research on MSN
NSRX: NS002 phase II topline results
By John Vandermosten, CFA NYSE: NSRX Nasus (NYSE: NSRX) reported topline results from its pharmacokinetic (PK) and ...
8 The Key Laboratory of Intelligent Preventive Medicine of Zhejiang Province, Hangzhou, China Correspondence to Professor Xifeng Wu, Department of Big Data in Health Science, School of Public Health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results